Cyclerion Therapeutics Inc

NASDAQ:CYCN   3:53:51 PM EDT
3.09
+0.12 (+4.04%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Cyclerion Therapeutics, Inc. Stock, NASDAQ:CYCN

301 BINNEY STREET, CAMBRIDGE, MA 02142
United States of America
Phone: 617-621-7722
Number of Employees:

Description

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion is advancing its portfolio of differentiated sGC stimulator programs with distinct pharmacologic and biodistribution properties that are designed to target tissues of greatest relevance to the diseases they are intended to treat. These programs include olinciguat in Phase 2 development for sickle cell disease, IW-6463 in Phase 1 development for serious and orphan central nervous system diseases, and two late-stage discovery programs targeting serious liver and lung diseases, respectively.